Combo of Cabozantinib With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic CRPC
Clinical trial NCT01995058 · TERMINATED
Trial details
- NCT number
- NCT01995058
- Sponsor
- Exelixis
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2014-11-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.